Related Experiment Video
Updated: Mar 30, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Advances in temporary mechanical support for treatment of cardiogenic shock
Marijan Koprivanac1, Marta Kelava2, Edward Soltesz1
1a 1 Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute , Cleveland, USA.
Abstract:
Mechanical circulatory support devices are the mainstay of treatment for severe cardiogenic shock refractory to pharmacologic therapy. Their evolution over the past few decades has been remarkable with a common theme of developing reliable, less bulky and more easily percutaneously implantable devices. The goal of this article is to review existing devices and advances in technology and provide insight into direction of further research and evolution of mechanical circulatory support devices for temporary support.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure VI: Adjunct Therapies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care

